SKIN & SEXUAL HEALTH RESEARCH

Melanotan-2

An α-MSH analogue studied for melanocyte stimulation (tanning) and sexual-arousal pathways.

Melanotan-2 (MT-2) is a potent α-MSH analogue studied for stimulating melanin production (tanning) and activating central sexual-arousal pathways. It is widely used in the research community, though its evidence base rests on mechanism and real-world use rather than formal human trials.

a-MSH AnalogueMelanocyte StimulationLibidoMC4R Agonist

Why BLP features Melanotan-2

Included because it has a clear melanocortin mechanism and an established real-world use following, shown transparently through its Established Use score. Formal human clinical trials are essentially absent, so its research maturity is Experimental—popularity is shown without being treated as evidence.

Mechanism

Potent α-MSH analogue that increases eumelanin (dark pigment).

Binds MC4R receptors in the brain, triggering sexual arousal and appetite suppression.

Described as providing UV-related effects even at low doses.

WHAT THE RESEARCH MEASURED

Research findings

Findings describe study outcomes, not expected personal results.

Reported research findings

  • No established formal human clinical trials define efficacy or safety; reported effects come from mechanism and research-community use.
  • Reported visible tanning within a few doses across skin types.
  • Reported stronger libido and arousal effects in research use.
  • Flushing, warmth, and possible nausea reported in the first few doses; existing moles/freckles may darken.

Preclinical findings

  • Melanocortin mechanism characterized in pharmacology research.
  • Pigmentation and arousal effects documented in preclinical and use-based settings.

Regulatory status

Melanotan-2 is investigational with no established formal human clinical trials. Sold and offered strictly for laboratory and research use.